Literature DB >> 35502392

Three-dimensional morphological analysis of true acetabulum in Crowe type IV hip dysplasia via standard-sized cup-simulated implantation.

Yuhui Yang1, Yuanchen Ma1, Qingtian Li1, Bofu Lin1, Hang Dong2, Qiujian Zheng1,3.   

Abstract

Background: Acetabular reconstruction in Crowe type IV developmental dysplasia of the hip (DDH) can be a challenging procedure for surgeons. A high risk of acetabular revision has been reported to be associated with extremely small acetabular prostheses. However, to our knowledge, quantitative morphological and coverage evaluations of the true acetabulum in Crowe IV hips have been infrequently conducted. Useful bony landmarks for acetabular reconstruction can also facilitate satisfactory intraoperative implantation. The aim of the present study was to investigate the anatomical size, orientation angles, and 2/3-dimensional (2D/3D) coverage parameters of the true acetabulum in Crowe IV hips; evaluate the feasibility of standard cup (>44 mm) implantation at the true acetabulum in Crowe IV hips; and identify the optimal position and useful bony landmarks of the acetabular reaming center in Crowe IV hips.
Methods: A total of 42 Crowe IV hips in 37 patients and 36 normal hips were included in this study. Based on pelvic 3D computed tomography (CT) reconstruction, anatomical size and integral volume of the true acetabulum were measured quantitatively. Through standard-size cup-simulated implantation, morphological assessments of the true acetabulum included Cup-CE, Cup-Sharp, acetabular anteversion angle, and thickness of the medial wall. Acetabular sector angles (ASAs) and the component coverage ratio were measured to provide coverage indices. Acetabular reconstruction was also performed at different vertical levels to measure medial bone stock and 3D component coverage. Bony landmarks for optimal component center location were also determined.
Results: The anatomic shape and volume of the acetabular triangle were significantly smaller in Crowe IV hips. Compared with the control group, the dysplastic acetabulum was more anteverted and abductive, with a thicker medial wall. According to the true acetabulum, bone stock was relatively sufficient in the posterior direction and prominently deficient in the anterosuperior and superior direction. The average 3D component coverage reached 79.89% by standard-sized cup implantation, with the most satisfactory coverage achieved at the true acetabulum (at the level of 13.32 mm above the transverse acetabular ligament). Regarding the component opening plane, the optimal component center was located at the midpoint between the superolateral and posteroinferior points of the true acetabulum. Conclusions: The most satisfactory coverage was achieved at the level of the true acetabulum, of which the most prominent deficiency was mainly located in the anterosuperior and superior directions. The optimal component center was determined to be the midpoint between the superolateral and posteroinferior points of the true acetabulum. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  3-dimensional (3D) coverage; Crowe type IV developmental dysplasia of the hip (DDH); bony landmark; morphological assessment; simulated implantation

Year:  2022        PMID: 35502392      PMCID: PMC9014161          DOI: 10.21037/qims-21-803

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  31 in total

1.  Optimal acetabular orientation for hip resurfacing.

Authors:  G Grammatopoulos; H Pandit; S Glyn-Jones; P McLardy-Smith; R Gundle; D Whitwell; H S Gill; D W Murray
Journal:  J Bone Joint Surg Br       Date:  2010-08

2.  Results of total hip arthroplasty differ in subtypes of high dislocation.

Authors:  George Hartofilakidis; George C Babis; Kalliopi Lampropoulou-Adamidou; John Vlamis
Journal:  Clin Orthop Relat Res       Date:  2013-04-10       Impact factor: 4.176

3.  Bulk structural autogenous grafts and allografts for reconstruction of the acetabulum in total hip arthroplasty. Sixteen-year-average follow-up.

Authors:  A A Shinar; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1997-02       Impact factor: 5.284

4.  Total hip arthroplasty with insertion of the acetabular component without cement in hips with total congenital dislocation or marked congenital dysplasia.

Authors:  M J Anderson; W H Harris
Journal:  J Bone Joint Surg Am       Date:  1999-03       Impact factor: 5.284

5.  Comparison of Three-Dimensional Planning-Assisted and Conventional Acetabular Cup Positioning in Total Hip Arthroplasty: A Randomized Controlled Trial.

Authors:  Elhadi Sariali; Nadia Boukhelifa; Yves Catonne; Hugues Pascal Moussellard
Journal:  J Bone Joint Surg Am       Date:  2016-01-20       Impact factor: 5.284

6.  Cementless total hip arthroplasty in patients with Crowe type-4 developmental dysplasia.

Authors:  Hakan Sofu; Vedat S Ahin; Sarper Gürsu; Timur Yildirim; Ahmet Issin; Nizamettin Koçkara
Journal:  Hip Int       Date:  2013-06-28       Impact factor: 2.135

7.  The asymmetric profile of the acetabulum.

Authors:  Eric Vandenbussche; Mohammed Saffarini; Fabienne Taillieu; Céline Mutschler
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

8.  Total hip replacement for developmental dysplasia of the hip.

Authors:  M Jasty; M J Anderson; W H Harris
Journal:  Clin Orthop Relat Res       Date:  1995-02       Impact factor: 4.176

9.  Shortening subtrochanteric osteotomy and cup placement at true acetabulum in total hip arthroplasty of Crowe III-IV developmental dysplasia: results of midterm follow-up.

Authors:  Alireza Manafi Rasi; Gholamhossein Kazemian; Mohammad Khak; Reza Zarei
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-11-25

10.  Best bone of acetabulum for cup component placement in Crowe types I to III dysplastic hips: a computer simulation study.

Authors:  Lin-Li Zheng; Yang-Yang Lin; Xiao-Yan Zhang; Qian-Hui Ling; Wei-Ming Liao; Pei-Hui Wu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.